Sun Pharma Canada Inc. Ranitidine Product Recall (2019-10-29)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 7703365A, 7702668A | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| B. RAN-Ranitidine 300mg | DIN 02336502 | Tablet | Ranitidine hydrochloride 300mg |
| 7703396A, 7703396B | - Recalling Firm
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Sun Pharma Canada Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| A. RAN-Ranitidine 150mg | DIN 02336480 | Tablet | Ranitidine hydrochloride 150mg |
A. RAN-Ranitidine 150mg
B. RAN-Ranitidine 300mg
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA)
Wholesalers, Healthcare Establishments, Retailers